Testing an experimental pill for weight loss in healthy or overweight adults
Part of Hormones & metabolism clinical trials.
This study tests an experimental pill (GZC8072) for weight loss. It is a phase 1 trial, meaning it is one of the first times the drug is given to people, and the focus is on safety and how the body handles it. You would receive either a single dose (if you are healthy) or multiple doses (if you are overweight or obese) to see how the medication works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 55 years old.
- Your BMI (a measure of body size based on height and weight) must be in a certain range: 19–28 for the single-dose part, or 24–35 for the multiple-dose part.
- You must be in generally good health, without significant heart, stomach, or other chronic conditions.
- You cannot have used certain medications, especially weight-loss drugs, in the past 6 months.
- If you are female, you cannot be pregnant or breastfeeding, and you must agree to use reliable contraception.
- You must be willing to follow strict study procedures, including repeated blood draws and dietary restrictions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental pill, BGM0504, to see if it helps overweight or obese adults lose weight safely. Participants will take the pill while continuing their usual diet and exercise routine.
This study tests a new injectable medicine for weight management in adults who are overweight. It aims to see how the medicine works in the body and how it affects weight.
This trial tests a new tablet drug in healthy people to see how safe it is and how the body processes it. It is an early-stage study, meaning it helps find the right dose and check for side effects.
This study tests a new medicine (NNC6989-0001) for people who are overweight or have obesity. It checks if the medicine is safe and how the body handles it. If eligible, you would receive the study drug and be monitored closely.
This trial tests a new tablet called MWN109 in healthy adults to see how safe it is and how the body handles it. It has two parts: one for people with a wide range of body weights, and another specifically for people with higher body weight. The results will help guide future studies.
This trial tests an experimental medication called ZP6590 given as injections. It's for men who are at a normal weight, overweight, or have obesity, and studies how safe and well-tolerated the drug is in different doses.
Hear when a new Healthy Subjects;Overweight or Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.